BLUEPRINT MEDICINES CORP
BLUEPRINT MEDICINES CORP
Action · US09627Y1091 · BPMC · A14SDD (XNAS)
Aperçu Indicateurs financiers
128,21 USD
0,23 % 0,30 USD
NASDAQ (XNAS) · Cours et graphiques actuels sur MoneyPeak
12.06.2025 19:59

Cours actuels de BLUEPRINT MEDICINES CORP

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
BPMC
USD
12.06.2025 19:59
128,21 USD
127,91 USD
+0,23 %
XLON: London
London
0HOJ.L
USD
12.06.2025 13:33
127,95 USD
127,91 USD
+0,03 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 0,35 % 27,81 % 41,67 % 38,49 % 18,88 % 83,45 %

Profil de l'entreprise pour BLUEPRINT MEDICINES CORP Action

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally available and potent inhibitor for the treatment of hepatocellular carcinoma. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered solid tumors, medullary thyroid carcinoma, and other solid tumors; BLU-701 and BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Fonds investis

Les fonds suivants ont investi dans : BLUEPRINT MEDICINES CORP investi :

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millions
190,44
Part (%)
0,45 %

Données de l'entreprise

Nom BLUEPRINT MEDICINES CORP
Société Blueprint Medicines Corporation
Symbole BPMC
Site web https://www.blueprintmedicines.com
Marché d'origine XNAS NASDAQ
WKN A14SDD
ISIN US09627Y1091
Type de titre Action
Secteur Healthcare
Industrie Medical - Pharmaceuticals
PDG Ms. Kathryn Haviland M.B.A.
Capitalisation boursière 5 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 0,6 T
Adresse 45 Sidney Street, 02139 Cambridge
Date d'introduction en bourse 2018-01-29

Symboles boursiers

Nom Symbole
Frankfurt 2L9.F
London 0HOJ.L
NASDAQ BPMC

Autres actions

Les investisseurs qui détiennent BLUEPRINT MEDICINES CORP ont également les actions suivantes dans leur portefeuille :
ADOBE INC
ADOBE INC Action
AMAZON.CO INC
AMAZON.CO INC Action
AMGEN INC
AMGEN INC Action
AUTODESK INC
AUTODESK INC Action
BGF-GL DYN.EQ.F.N.A2 EO-H
BGF-GL DYN.EQ.F.N.A2 EO-H Fonds
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
FTC SOLAR INC
FTC SOLAR INC Action
LB.HESS.THR.IS.06B/19
LB.HESS.THR.IS.06B/19 Obligation
LITTELFUSE INC
LITTELFUSE INC Action
MICRON TECHNOLOGIESLOGY INC
MICRON TECHNOLOGIESLOGY INC Action
MICROSOFT CORP
MICROSOFT CORP Action
QUALCOMM INC
QUALCOMM INC Action
VERISIGN INC
VERISIGN INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025